We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Biomarker Test Developed for Chronic Fatigue Syndrome

By LabMedica International staff writers
Posted on 16 May 2019
Print article
Image: A nanoelectronics assay: stressed blood cells could be a biomarker for chronic fatigue (Photo courtesy of The Scientist).
Image: A nanoelectronics assay: stressed blood cells could be a biomarker for chronic fatigue (Photo courtesy of The Scientist).
Myalgic encephalomyelitis, or chronic fatigue syndrome (ME/CFS), is a serious condition that may affect up to 2.5 million people in the USA. Symptoms include extreme tiredness, difficulty sleeping, trouble with thinking and remembering things, muscle pain and aches, a recurring sore throat, and tender lymph nodes.

Currently, physicians can only diagnose ME/CFS by examining a person's symptoms and medical history, and by excluding other possible illnesses. This can make the diagnosis process difficult, lengthy, and inaccurate. A new diagnostic test looks at how a person's immune cells react to stress.

Scientists at the Stanford University School of Medicine (Stanford, CA, USA) have developed a nanoelectronics assay designed as an ultrasensitive assay capable of directly measuring biomolecular interactions in real time, at low cost, and in a multiplex format. The team applied the test to the blood samples of 40 people, 20 of who had ME/CFS and 20 whom did not.

The scientists used a nanoelectronic assay, which measures small changes in energy to assess the health of immune cells and blood plasma, to see how the immune cells and blood plasma process stress. To develop the test, the team took advantage of "advancements in micro/nanofabrication, direct electrical detection of cellular and molecular properties, microfluidics, and artificial intelligence techniques."

The test detects "biomolecular interactions in real time" by using thousands of electrodes to create an electrical current, and by using small chambers that contain blood samples with only immune cells and blood plasma. Inside the small chambers, the immune cells and plasma interact with the electrical current, altering its flow. The scientists used salt to stress the blood samples of some people with ME/CFS and some people without the condition. They then assessed the changes in electrical current. Their test accurately identified all of the people with ME/CFS without misidentifying any of the people who did not have the condition.

The team concluded that they had observed robust impedance modulation difference of the samples in response to hyperosmotic stress can potentially provide a unique indicator of ME/CFS. Moreover, using supervised machine learning algorithms, they developed a classifier for ME/CFS patients capable of identifying new patients, required for a robust diagnostic tool.

Rahim Esfandyarpour, PhD, a Bioengineer and first author of the study, said, “Using the nanoelectronics assay, we can add controlled doses of many different potentially therapeutic drugs to the patient's blood samples and run the diagnostic test again.” The study was published on April 29, 2019, in the journal Proceedings of the National Academy of Sciences.

Related Links:
Stanford University School of Medicine

Gold Member
Troponin T QC
Troponin T Quality Control
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Serum Toxicology Benzodiazepine Assay
DRI Serum Toxicology Benzodiazepine Assay
New
Flow Cytometer
BF – 710

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The FDA clearance for the QIAstat-Dx Respiratory Panel Mini test follows the recent approval of QIAstat-Dx Respiratory Panel Plus (Photo courtesy of QIAGEN)

Respiratory Panel to Help Clinicians Make Precise Treatment Decisions in Outpatient Settings

Respiratory tract infections are the primary reason for visits to emergency departments and subsequent hospitalizations. In the U.S., it is estimated that there are up to 41 million cases of influenza... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image: The new technique allows properties of cancer cells and their surrounding tissue to be analyzed in detail at single-cell level (Photo courtesy of Universität Helsinki/Karolina Punovuori)

New Imaging Method Opens Door to Precision Diagnostics for Head and Neck Cancers

Head and neck cancers, while considered rare, represent a significant portion of cancer cases and have seen a notable increase over the past 30 years. These cancers encompass various malignant tumors that... Read more